Shift Bioscience

Shift Bioscience

Shift Bioscience is using AI-guided cellular rejuvenation to defeat the diseases of aging. Our mission is to extend human lifespan by harnessing advanced machine learning techniques to develop therapies that reverse cellular aging.

Leader

Shift Bioscience

Daniel Ives, CEO and founder of Shift Bioscience, is a mitochondrial biologist trained at the University of Cambridge. He founded Shift Bioscience in 2017 to explore the biology of aging, and has since pivoted the company towards machine learning, creating innovative solutions to reverse cellular aging.

About

Shift Bioscience is pioneering the application of AI in aging research. The company has developed an Epigenetic Aging Clock, a powerful biomarker for cellular age, and is focused on identifying interventions that can reverse the age of cells. Shift Bioscience aims to bring these discoveries from the lab to clinical trials within five years, and to market within ten.

Core Projects

No items found.

Milestones

No items found.

Collaborative Opportunities

Is your organization ready to join the fight against aging?

Apply to become a Certified Vitalist Organization and align with others dedicated to this mission

CERTIFICATION APPLICATION